Fansa, Sima
Ghusn, Wissam
Tama, Elif
Nicolalde, Bryan
Anazco, Diego
Andre, Stacy D.’
Faubion, Stephanie S.
Shufelt, Chrisandra L.
Acosta, Andres
Hurtado Andrade, Maria D.
Article History
Received: 24 April 2024
Accepted: 26 July 2024
First Online: 30 July 2024
Declarations
:
: MDHA is supported by NIH (K12-AR084222). AA is supported by NIH (K23-DK114460). AA is a stockholder in Gila Therapeutics, Phenomix Sciences; he served as a consultant for Rhythm Pharmaceuticals, General Mills, Currax, Nestle, Amgen, Structure, and Boehringer Ingelheim. There are no other disclosures. The other authors declare no conflicts of interest. CLS is supported by NIH (R01-HD106096).